Background Patients who have had a stroke with unknown time of onset have been previously
excluded from thrombolysis. We aimed to establish whether intravenous alteplase is safe …

Background Under current guidelines, intravenous thrombolysis is used to treat acute stroke
only if it can be ascertained that the time since the onset of symptoms was less than 4.5 …

Background: White matter hyperintensities of presumed vascular origin (WMH) are a common
finding in elderly people and a growing social malady in the aging western societies. As a …

Background Many patients with stroke are precluded from thrombolysis treatment because
the time from onset of their symptoms is unknown. We aimed to test whether a mismatch in …

Aims Long-term sequelae may occur after SARS-CoV-2 infection. We comprehensively
assessed organ-specific functions in individuals after mild to moderate SARS-CoV-2 infection …

Background Cerebral small vessel disease (CSVD) is a common neurological disease present
in the ageing population that is associated with an increased risk of dementia and stroke. …

Background and Purpose— In the early days after ischemic stroke, information on structural
brain damage from MRI supports prognosis of functional outcome. It is rated widely by the …

Background Recent evidence suggests a beneficial effect of endovascular thrombectomy in
acute ischaemic stroke with large infarct; however, previous trials have relied on multimodal …

Rationale In about 20% of acute ischemic stroke patients stroke occurs during sleep. These
patients are generally excluded from intravenous thrombolysis. MRI can identify patients …

Background and Purpose— About 50% to 80% of stroke survivors present with somatosensory
deficits. Somatosensory deficits because of an ischemic stroke are determined by the …